3 Followers on Owler

Epidarex

Epidarex Capital is a venture capital firm involved in early stage, startup and growth capital investments. Read more

Sinclair Dunlop's photo - Managing Partner of Epidarex

Managing Partner

Sinclair Dunlop

CEO Approval Rating

70/100

Founded:

06/2010

Status:

Investment CompanyIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 0 a good estimate for Epidarex's Employee count?

Epidarex Acquisitions

No recent acquisitions found related to Epidarex

Epidarex Funding History

Since Epidarex was founded in 06/2010, it has participated in 2 rounds of funding. In total Epidarex has raised $206.3M. Epidarex's last funding round was on Jun 2020 for a total of $126.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Investment Fund
Jun 2020
$126M
-
Investment Fund
May 2014
$80.3M

Since Epidarex was founded in 06/2010, it has participated in 2 rounds of funding. In total Epidarex has raised $206.3M. Epidarex's last funding round was on Jun 2020 for a total of $126.0M

Epidarex Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

LUNAC is an England-based biopharmaceutical company that researches and develops anticoagulant therapies for the treatment of blood clotting disorders.
$6.7M
May 12, 2021
Equity
-
Slate Bio is a Virginia-based biopharmaceutical company that develops and commercializes T cell therapies for the treatment of autoimmune and inflammatory diseases.
$1.8M
Jan 18, 2021
Seed
-
Theolytics is a biotechnology company that develops and commercializes oncolytic viral therapeutics for the treatment of cancer.
$6.8M
Jan 06, 2021
Series A
-
Eternygen is a contract research organization that offers clinical trial and consulting services to the pharmaceutical and biotechnology industries.
$5.9M
Oct 25, 2020
Series A
-
Topas is a biotechnology company that develops and commercializes novel therapeutics for the treatment of immune-mediated and autoimmune diseases.
$26M
Oct 18, 2020
Series B
-

Epidarex News

October 26, 2020MarketScreener

Announces the First Closing of its Series A2 Funding Round

(marketscreener.com) a sodium coupled citrate transporter in the liver - which has a broad effect on ... See more »
October 20, 2020Global University Venturing

Topas tackles $26m series B - Global University Venturing

Topas Therapeutics, which is exploiting University of Hamburg research, has pocketed $26m in its seri... See more »
September 29, 2020San Diego Business Journal

Libra Therapeutics Raises $25M

Company Aims to Restore Cellular Balance... See more »
September 25, 2020Global Legal Chronicle

Libra Therapeutics' $29 Million Series A Financing

Wilson Sonsini Goodrich & Rosati advised Libra Therapeutics on the deal. Libra Therapeutics launched ... See more »
September 24, 2020PharmaLive

Libra Raises $29 Million to Tackle Neurodegenerative Diseases

With $29 million in the company's pocket, biotech Libra Therapeutics launched to take on neurodegener... See more »

Epidarex Press Releases

Social Media

Epidarex Headquarters

7910 Woodmont Ave Suite 1210

Bethesda, Maryland20814

301-298-5455

Driving Directions »

Trending Companies

Epidarex Summary

ABOUT

Overview

Epidarex Capital is a venture capital firm involved in early stage, startup and growth capital investments. Epidarex was founded in 06/2010. Epidarex's headquarters is located in Bethesda, Maryland, USA 20814. It has raised 206.3M in 2 rounds. The lat...

CEO

Epidarex's Managing Partner, Sinclair Dunlop, currently has an approval rating of 70%. Epidarex's primary competitors are

Frequently Asked Questions about Epidarex

  1. When was Epidarex founded?

    Epidarex was founded in 06/2010
  2. Who is Epidarex's CEO?

    Epidarex's CEO is Sinclair Dunlop
  3. How much revenue does Epidarex generate?

    Epidarex generates $ < 1M in revenue
  4. How much funding does Epidarex have?

    Epidarex has historically raised $206.3M in funding
  1. Where is Epidarex's headquarters?

    Epidarex's headquarters is in Bethesda Maryland, USA
  2. How many employees does Epidarex have?

    Epidarex has 0 employees
  3. Who has Epidarex invested in?

    Epidarex's has invested in companies such as Lunac Therapeutics, Slate Bio, Theolytics